|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 88.85 EUR | +0.77% |
|
+1.60% | -1.01% |
| Apr. 23 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
| Apr. 23 | Sector Update: Health Care | MT |
May 20 (Reuters) - Sanofi on Friday won expanded U.S. approval for its best-selling Dupixent injection to treat an allergic inflammation of the esophagus, the U.S. Food and Drug Administration said. (Reporting by Ludwig Burger; Additional reporting by Eva Mathews; Editing by Maju Samuel)
| 1st Jan change | Capi. | |
|---|---|---|
| -1.01% | 117B | |
| +27.92% | 659B | |
| +27.68% | 557B | |
| -4.59% | 359B | |
| +16.38% | 322B | |
| +9.39% | 297B | |
| +6.30% | 215B | |
| +4.80% | 210B | |
| -6.05% | 200B | |
| -8.58% | 149B |
SANOFI 
